Aytu BioPharma regains Nasdaq minimum bid price compliance

AYTU BIOPHARMA, INC

Received Nasdaq notification on Jan 23, 2023 confirming bid price compliance.
Closing bid price exceeded $1.00 for 10 consecutive business days (Jan 6-20, 2023).
Company is now fully compliant with all Nasdaq listing rules; matter closed.

item 7.01 item 8.01 item 9.01

AYTU BIOPHARMA, INC filing history →

Source: SEC EDGAR

accession 0001558370-23-000493

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.